SCHEDULE 13G/A 0001988788 XXXXXXXX LIVE 1 Common Stock, par value $0.0001 per share 06/30/2025 0001919246 Pelthos Therapeutics Inc. 171126204 4020 Stirrup Creek Drive, Suite 110 Durham NC 27703 Rule 13d-1(c) AME Equities LLC b NC 0.00 0.00 0.00 0.00 0.00 N 0 OO This constitutes an exit filing for the reporting person. Ruth Friedman b X1 0.00 0.00 0.00 0.00 0.00 N 0 IN This constitutes an exit filing for the reporting person. Pelthos Therapeutics Inc. 4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703 (i) AME Equities LLC, a North Carolina limited liability company ("AME"); and (ii) Ruth Friedman ("Ms. Friedman"). The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons". Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed as Exhibit 1 to the Statement on Schedule 13G filed by the Reporting Persons with the U.S. Securities and Exchange Commission (the "SEC") on March 1, 2024 (the "Schedule 13G"), pursuant to which such Reporting Persons have agreed to file the Schedule 13G, this Amendment No. 1 to Schedule 13G (the "Amendment") and all subsequent amendments to the Schedule 13G and the Amendment jointly in accordance with the provisions of Rule 13d-1(k) of the Act. The filing of this Amendment should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the shares of common stock, par value $0.0001 per share, of the issuer (the "Common Stock") reported herein. The principal business address of each of the Reporting Persons is 2011 Bradford Hall Place, Charlotte, NC 28270. AME is a North Carolina limited liability company. Ms. Friedman is a citizen of the United States. Y The purpose of this Amendment is to amend and supplement the Schedule 13G in order to update the beneficial ownership information on the cover pages and in Item 4 in the Schedule 13G, including to indicate that each of the Reporting Persons has ceased to be the beneficial owner of more than five percent of the outstanding shares of Common Stock and to amend Item 5 of the Schedule 13G accordingly. This Amendment constitutes an exit filing for each of the Reporting Persons. The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover pages to this Amendment and is incorporated herein by reference for each such Reporting Person. None of the Reporting Persons beneficially owns any shares of Common Stock. Ms. Friedman, as the manager of AME, has shared power to vote and/or dispose of any shares of Common Stock beneficially owned by AME. By reason of the provisions of Rule 13d-3 of the Act, Ms. Friedman may be deemed to beneficially own any shares of Common Stock beneficially owned by AME. 0 % (A) AME: 0.00 (B) Ms. Friedman: 0.00 (A) AME: 0.00 (B) Ms. Friedman: 0.00 (A) AME: 0.00 (B) Ms. Friedman: 0.00 (A) AME: 0.00 (B) Ms. Friedman: 0.00 N Y Y Y N See Exhibit 1 filed with the Schedule 13G. Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. AME Equities LLC /s/ Ruth Friedman 08/13/2025 Ruth Friedman /s/ Ruth Friedman 08/13/2025 LIST OF EXHIBITS Exhibit No. 1 - Joint Filing Agreement, dated March 1, 2024 (incorporated by reference to Exhibit 1 to the Schedule 13G filed by the Reporting Persons with the SEC on March 1, 2024).